We are live on ! Find out more
ISEE

IVERIC bio, Inc. Common Stock

Delisted

ISEE was delisted on the 10th of July, 2023.

256 hedge funds and large institutions have $5.32B invested in IVERIC bio, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 106 funds opening new positions, 58 increasing their positions, 69 reducing their positions, and 73 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more funds holding in top 10

Funds holding in top 10: 1540 (+25)

129% more call options, than puts

Call options by funds: $538M | Put options by funds: $234M

49% more capital invested

Capital invested by funds: $3.58B → $5.32B (+$1.74B)

45% more first-time investments, than exits

New positions opened: 106 | Existing positions closed: 73

15% more funds holding

Funds holding: 223256 (+33)

16% less repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 69

Holders
256
Holders Change
+33
Holders Change %
+14.8%
% of All Funds
4.02%
Holding in Top 10
40
Holding in Top 10 Change
+25
Holding in Top 10 Change %
+166.67%
% of All Funds
0.63%
New
106
Increased
58
Reduced
69
Closed
73
Calls
$538M
Puts
$234M
Net Calls
+$303M
Net Calls Change
+$293M
Name Holding Trade Value Shares
Change
Change in
Stake
Janus Henderson Group
101
Janus Henderson Group
United Kingdom
$6.17M -$160M -4,530,378 -97%
CM
102
Crystalline Management
Canada
$6.1M +$5.47M +155,000 New
KC
103
Kellner Capital
New York
$6.02M +$5.41M +153,129 New
CCM
104
Cinctive Capital Management
New York
$5.9M +$5.29M +149,923 New
California State Teachers Retirement System (CalSTRS)
105
California State Teachers Retirement System (CalSTRS)
California
$5.85M -$81.7K -2,315 -2%
WP
106
Woodline Partners
California
$5.54M -$5.25M -148,758 -51%
HS
107
HighVista Strategies
Massachusetts
$5.49M +$1.46M +41,458 +42%
Two Sigma Advisers
108
Two Sigma Advisers
New York
$5.32M +$4.78M +135,300 New
SFM
109
Sphera Funds Management
Israel
$5.29M -$3.43M -97,177 -42%
SC
110
Shay Capital
New York
$5.21M +$4.68M +132,500 New
Ohio Public Employees Retirement System (OPERS)
111
Ohio Public Employees Retirement System (OPERS)
Ohio
$5.19M +$4.66M +132,000 New
ACP
112
Acuta Capital Partners
California
$5.17M -$5.26M -149,046 -53%
CC
113
Centiva Capital
New York
$5.06M +$4.54M +128,544 New
MS
114
Maven Securities
Jersey
$4.89M +$4.39M +124,278 New
AFM
115
Anson Funds Management
Texas
$4.83M +$4.33M +122,650 New
Legal & General Group
116
Legal & General Group
United Kingdom
$4.46M -$296K -8,374 -7%
NFGH
117
Nan Fung Group Holdings
Hong Kong
$4.41M
BMCM
118
Black Maple Capital Management
Wisconsin
$4.28M +$3.84M +108,720 New
WAM
119
Wolverine Asset Management
Illinois
$4.26M +$3.82M +108,271 New
FC
120
FORA Capital
Florida
$4.26M +$3.82M +108,217 New
CCM
121
Crabel Capital Management
California
$4.16M +$3.73M +105,792 New
AA
122
ALPS Advisors
Colorado
$3.99M +$391K +11,084 +12%
BFM
123
Boothbay Fund Management
New York
$3.97M +$2.14M +60,713 +151%
State of Wisconsin Investment Board
124
State of Wisconsin Investment Board
Wisconsin
$3.93M -$181K -5,135 -5%
Wells Fargo
125
Wells Fargo
California
$3.89M +$537K +15,202 +18%

ISEE Hedge Fund Activity: Q2 2023 in Review

256 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in IVERIC bio, Inc. Common Stock (ISEE) for Q2 2023, worth a combined $5.32B — up 49% from $3.58B a quarter earlier.

Buyers outnumbered sellers: 106 funds opened new ISEE positions and 73 closed out — a net gain of 33 holders — while 58 added to existing stakes and 69 trimmed.

The largest buyer was UBS O'Connor, opening a new position worth an estimated $206M. The largest seller was T. Rowe Price Associates, cutting an estimated $238M.

  • 256 institutional investors held IVERIC bio, Inc. Common Stock (ISEE) as of Q2 2023, up from 223 in Q1 2023.
  • Funds reported $5.32B of IVERIC bio, Inc. Common Stock stock for Q2 2023, up 49% quarter-over-quarter.
  • 106 funds opened new IVERIC bio, Inc. Common Stock positions in Q2 2023 and 73 closed out, a net change of +33 holders.
  • The largest IVERIC bio, Inc. Common Stock buyer in Q2 2023 was UBS O'Connor, an estimated $206M added.
  • The largest IVERIC bio, Inc. Common Stock seller in Q2 2023 was T. Rowe Price Associates, an estimated $238M sold.

Based on aggregated 13F filings for Q2 2023.